Share this post on:

Name :
HOXA9 Polyclonal Antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
Polyclonal antibody to HOXA9

Tested applications :

Species reactivity :
Human, Mouse

Alternative names :
HOXA9 antibody; ABD-B antibody; HOX1 antibody; HOX1.7 antibody; HOX1G antibody; homeobox A9 antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
Antigen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-190 of human HOXA9 (NP_689952.1).

Clonality :

Formulation :
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Storage instructions :
Store at -20℃. Avoid freeze / thaw cycles.

Applications :
WB 1:500 – 1:2000

Background :
Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Required for induction of E-selectin and VCAM-1, on the endothelial cells surface at sites of inflammation.

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites:
Popular product recommendations:
Anti-Mouse IL-1R Antibody (JAMA-147)
DDX3 Antibody (YA784): DDX3 Antibody (YA784) is a non-conjugated and Mouse origined monoclonal antibody about 73 kDa, targeting to DDX3 (6G8). It can be used for WB,ICC/IF,IP,ChIP assays with tag free, in the background of Human, Rat, Mouse, Monkey.

Share this post on:

Author: Gardos- Channel